HPS Pharmacies wish to advise that Sandoz is experiencing a supply interruption for modified-release oxycodone tablets as follows:
Normal supplies of Oxycodone Sandoz 5mg modified-release tablets are expected to return in late April 2022. The Oxycontin® brand is also experiencing a supply interruption of the 10mg presentation. However, alternative brands of 10mg modified-release oxycodone tablets are available.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Sandoz on 1800 726 369 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates